526445 — Indrayani Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.07bn
- IN₹2.89bn
- IN₹1.63bn
Annual cashflow statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -109 | 42.3 | 119 |
| Depreciation | |||
| Non-Cash Items | 21.2 | — | 10.6 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 88.8 | -11 | -1.48 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 5.18 | 34.7 | 162 |
| Capital Expenditures | -3.83 | -0.631 | -239 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -1.8 | 6.49 | -235 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -5.63 | 5.86 | -474 |
| Financing Cash Flow Items | -19.4 | -18.6 | -127 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -7.3 | -32.3 | 327 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -7.76 | 8.19 | 15.3 |